EL7.AI
StocksUpdated×2•Originally published 16 April 2026•Updated 17 April 2026•
1 min read

Philip Morris Stock Undervalued Despite Strong Shift to Smoke-Free Products

Key Facts

1Philip Morris (PM) stock is trading at a low valuation despite reasonable growth and strong cash flow.
2The transition to smoke-free products like IQOS and ZYN is driving superior growth and margin profiles.
3Risks include potential ZYN growth deceleration and increasing regulatory threats.

Philip Morris International (PM) is preparing to release its Q1 earnings report, with analyst estimates indicating a potential upside surprise in adjusted earnings per share (EPS). Trefis analysts highlight that the stock remains undervalued relative to its robust cash flows and strategic shift toward smoke-free products like IQOS and ZYN. Historically, PM stock tends to react sharply to earnings releases, potentially providing a tactical short-term trading opportunity. While these smoke-free alternatives continue to drive superior margin expansion, the outlook for the remainder of the year is tempered by limited price growth prospects as the stock nears fair valuation. Overall, a disconnect persists between the company's solid fundamentals and its market valuation ahead of the financial results. The Q1 performance will be a key catalyst in determining if the stock can trigger a near-term rally.